Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 106, Issue 10, 2010, Pages 1481-1486

  Bos, J Martijn ^a   Maron, Barry J ^c   Ackerman, Michael J ^a,b   Haas, Tammy S ^c   Sorajja, Paul ^b   Nishimura, Rick A ^b   Gersh, Bernard J ^b   Ommen, Steve R ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DEFIBRILLATOR; DEVICE THERAPY; FAMILY HISTORY; FEMALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 78149444773     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.06.077     Document Type: Article

References (32)

1. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
2. B.J. Maron, J.J. Doerer, T.S. Haas, D.M. Tierney, and F.O. Mueller Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 19802006 Circulation 119 2009 1085 1092
3. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer III, P. Spirito, F.J. ten Cate, and E.D. Wigle American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
4. B.J. Maron, I. Olivotto, P. Spirito, S.A. Casey, P. Bellone, T.E. Gohman, K.J. Graham, D.A. Burton, and F. Cecchi Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population Circulation 102 2000 858 864
5. P. Spirito, C.E. Seidman, W.J. McKenna, and B.J. Maron The management of hypertrophic cardiomyopathy N Engl J Med 336 1997 775 785
6. B.J. Maron, W.-K. Shen, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, G.H. Bardy, S. Favale, R.F. Rea, G. Boriani, N.A. Estes III, and P. Spirito Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 342 2000 365 373
7. B.J. Maron, P. Spirito, W.-K. Shen, T.S. Haas, F. Formisano, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, T. Lawrenz, G. Boriani, N.A. Estes III, S. Favale, M. Piccininno, S.L. Winters, M. Santini, S. Betocchi, F. Arribas, M.V. Sherrid, G. Buja, C. Semsarian, and P. Bruzzi Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412
8. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A.J. Moss, R.J. Myerburg, S.G. Priori, M.A. Quinones, D.M. Roden, M.J. Silka, C. Tracy, S.C. Smith Jr, A.K. Jacobs, C.D. Adams, E.M. Antman, J.L. Anderson, S.A. Hunt, J.L. Halperin, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, J.J. Blanc, A. Budaj, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Tamargo, and J.L. Zamorano ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484
9. P.M. Elliott, J. Poloniecki, S. Dickie, S. Sharma, L. Monserrat, A. Varnava, N.G. Mahon, and W.J. McKenna Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
10. B.J. Maron, J.A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett, A.J. Moss, C.E. Seidman, and J.B. Young Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
11. W.J. McKenna, and E.R. Behr Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death Heart 87 2002 169 176
12. P.M. Elliott, J.R. Gimeno Blanes, N.G. Mahon, J.D. Poloniecki, and W.J. McKenna Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy Lancet 357 2001 420 424
13. B.J. Maron Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy Heart 89 2003 977 978
14. B.J. Maron, N.A.M. Estes, M.S. Maron, A.K. Almquist, M.S. Link, and J.E. Udelson Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy Circulation 107 2003 2872 2875
15. I. Olivotto, B.J. Maron, A. Montereggi, F. Mazzuoli, A. Dolara, and F. Cecchi Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy J Am Coll Cardiol 33 1999 2044 2051
16. P. Spirito, C. Autore, C. Rapezzi, P. Bernabo, R. Badagliacca, M.S. Maron, S. Bongioanni, F. Coccolo, N.A. Estes, C.S. Barilla, E. Biagini, G. Quarta, M.R. Conte, P. Bruzzi, and B.J. Maron Syncope and risk of sudden death in hypertrophic cardiomyopathy Circulation 119 2009 1703 1710
17. P. Spirito, P. Bellone, K.M. Harris, P. Bernabo, P. Bruzzi, and B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785
18. R.G. Hauser, and B.J. Maron Lessons from the failure and recall of an implantable cardioverter-defibrillator Circulation 112 2005 2040 2042
19. I. Jayatilleke, A. Doolan, J. Ingles, M. McGuire, V. Booth, D.R. Richmond, and C. Semsarian Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy Am J Cardiol 93 2004 1192 1194
20. B.J. Maron, and P. Spirito Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy J Cardiovasc Electrophysiol 19 2008 1118 1126
21. A. Woo, D. Monakier, L. Harris, A. Hill, P. Shah, E.D. Wigle, H. Rakowski, E. Rozenblyum, and D.A. Cameron Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy Heart 93 2007 1044 1045
22. R.A. Nishimura, and S.R. Ommen Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar? JAMA 298 2007 452 454
23. F. Cecchi, I. Olivotto, A. Montereggi, G. Santoro, A. Dolara, and B.J. Maron Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population J Am Coll Cardiol 26 1995 1529 1536
24. B.J. Maron, S.A. Casey, L.C. Poliac, T.E. Gohman, A.K. Almquist, and D.M. Aeppli Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 281 1999 650 655
25. K.A. Ellenbogen, J.H. Levine, R.D. Berger, J.P. Daubert, S.L. Winters, E. Greenstein, A. Shelby, A. Schaechter, H. Subacius, and A. Kadish Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782
26. A.S. Adabag, B.J. Maron, E. Appelbaum, C.J. Harrigan, J.L. Buros, C.M. Gibson, J.R. Lesser, C.A. Hanna, J.E. Udelson, W.J. Manning, and M.S. Maron Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
27. F.A. Cuoco, W.H. Spencer III, V.L. Fernandes, C.D. Nielsen, S. Nagueh, J.L. Sturdivant, R.B. Leman, J.M. Wharton, and M.R. Gold Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy J Am Coll Cardiol 52 2008 1718 1723
28. P.M. Elliott, J.R. Gimeno, M.T. Tome, J. Shah, D. Ward, R. Thaman, J. Mogensen, and W.J. McKenna Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy Eur Heart J 27 2006 1933 1941
29. M.S. Maron, I. Olivotto, S. Betocchi, S.A. Casey, J.R. Lesser, M.A. Losi, F. Cecchi, and B.J. Maron Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
30. C.J. McLeod, S.R. Ommen, M.J. Ackerman, P.L. Weivoda, W.K. Shen, J.A. Dearani, H.V. Schaff, A.J. Tajik, and B.J. Gersh Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur Heart J 28 2007 2583 2588
31. M.S. Maron, J.J. Finley, J.M. Bos, R.H. Hauser, W.J. Manning, T.S. Haas, J.R. Lesser, J.E. Udelson, M.J. Ackerman, and B.J. Maron Prevalence, clinical significance and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 2008 1541 1549
32. G. Lin, R.A. Nishimura, B.J. Gersh, D. Phil, S.R. Ommen, M.J. Ackerman, and P.A. Brady Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy Heart 95 2009 709 714